Viracta Therapeutics, Inc.
VIRX
$0.0175
-$0.0038-17.84%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.13M | 30.01M | 39.57M | 53.83M | 63.11M |
| Total Receivables | -- | -- | -- | 281.00K | 295.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 671.00K | 1.07M | 1.39M | 857.00K | 1.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.80M | 31.07M | 40.95M | 54.96M | 64.44M |
|
|
|||||
| Total Current Assets | 21.80M | 31.07M | 40.95M | 54.96M | 64.44M |
| Net Property, Plant & Equipment | 111.00K | 206.00K | 338.00K | 464.00K | 589.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 44.00K | 44.00K | 44.00K | 1.26M | 1.41M |
| Total Assets | 21.96M | 31.32M | 41.33M | 56.69M | 66.44M |
|
|
|||||
| Total Accounts Payable | 1.82M | 1.29M | 2.41M | 2.44M | 2.36M |
| Total Accrued Expenses | 9.85M | 8.55M | 8.99M | 10.38M | 8.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.91M | 18.82M | 18.86M | 25.56M | 25.56M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 28.58M | 28.65M | 30.25M | 38.37M | 36.43M |
|
|
|||||
| Total Current Liabilities | 28.58M | 28.65M | 30.25M | 38.37M | 36.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 28.58M | 28.65M | 30.25M | 38.37M | 36.43M |
|
|
|||||
| Common Stock & APIC | 288.83M | 282.13M | 280.71M | 278.79M | 276.79M |
| Retained Earnings | -295.46M | -284.90M | -275.07M | -265.93M | -252.17M |
| Treasury Stock & Other | 9.00K | -5.00K | -6.00K | 9.00K | -65.00K |
| Total Common Equity | -6.62M | -2.78M | 5.63M | 12.87M | 24.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 5.45M | 5.45M | 5.45M | 5.45M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 5.45M | 5.45M | 5.45M | 5.45M |
|
|
|||||
| Total Common Equity | -6.62M | -2.78M | 5.63M | 12.87M | 24.56M |
| Total Preferred Equity | -- | 5.45M | 5.45M | 5.45M | 5.45M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.62M | 2.67M | 11.08M | 18.32M | 30.01M |
|
|
|||||
